However, because of its role in mediating signaling events from other proteins, with a primary focus on NOTCH1 signaling, γ‐secretase has become a therapeutic target in cancer and immunologic diseases and may very well be a target in other conditions (Espinoza et al, 2013; Andersson & Lendahl, 2014). Here, NOTCH1 is linked to cancer.